MYND Life Sciences Inc. (MYNDF) Research

MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the United States, concentrating on therapeutic compounds that possess neuro-anti-inflammatory properties. A significant part of its research involves the in-depth study of psilocin and psilocybin extracts, along with their various analogs. The company's principal office is situated in Kelowna, Canada.

Market snapshot

Symbol
MYNDF
Price
$0.01
Day change
0.00%
Market cap
$3.3M
P/E ratio
-2.18x
52-week range
0.0081-0.0675
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Bioxytran, Inc. (BIXT)
  • BioVaxys Technology Corp. (BVAXF)
  • Burzynski Research Institute, Inc. (BZYR)
  • Mosaic ImmunoEngineering Inc. (CPMV)
  • Futura Medical plc (FAMDF)
  • Glow Lifetech Corp. (GLWLF)
  • Kane Biotech Inc. (KNBIF)
  • Sorrento Therapeutics, Inc. (SRNE)

Open MYND Life Sciences Inc. (MYNDF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.